isoxazoles has been researched along with Encephalopathy, Toxic in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (71.43) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahn, W; Kim, YC; Kim, YH; Lee, PB; Lee, SC; Lim, YJ; Park, J | 1 |
| Gendle, DF; Grayson, B; Idris, NF; Lesage, AS; Mackie, C; McLean, SL; Neill, JC; Pemberton, DJ | 1 |
| Chaudhry, V; Umapathi, T | 1 |
| Dryhurst, G; Foster, SB; Miller, KE; Tang, H | 1 |
| Kumar, A; Kumar, P; Naidu, PS; Padi, SS | 1 |
| Aguirre, N; de la Torre, R; Goñi-Allo, B; Hervias, I; Lasheras, B; Mathúna, BO; Puerta, E | 1 |
| Bai, F; Jones, DC; Lau, SS; Monks, TJ | 1 |
1 review(s) available for isoxazoles and Encephalopathy, Toxic
| Article | Year |
|---|---|
Toxic neuropathy.
Topics: Animals; Boronic Acids; Bortezomib; Clinical Trials as Topic; Epothilones; Genetic Therapy; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Isoxazoles; Leflunomide; Neuritis; Neuroprotective Agents; Neurotoxicity Syndromes; Organoplatinum Compounds; Oxaliplatin; Peripheral Nervous System Diseases; Pyrazines; Pyridoxine; Thalidomide | 2005 |
6 other study(ies) available for isoxazoles and Encephalopathy, Toxic
| Article | Year |
|---|---|
The neurological safety of epidural parecoxib in rats.
Topics: Animals; Cyclooxygenase 2 Inhibitors; Ethanol; Gait; Injections, Epidural; Isoxazoles; Male; Neurologic Examination; Neurotoxicity Syndromes; Pain Measurement; Pain Threshold; Rats; Rats, Sprague-Dawley; Risk Assessment; Spinal Cord; Time Factors | 2011 |
PNU-120596, a positive allosteric modulator of α7 nicotinic acetylcholine receptors, reverses a sub-chronic phencyclidine-induced cognitive deficit in the attentional set-shifting task in female rats.
Topics: Allosteric Regulation; alpha7 Nicotinic Acetylcholine Receptor; Animals; Attention; Behavior, Animal; Brain; Cognition Disorders; Discrimination Learning; Disease Models, Animal; Drug Interactions; Female; Half-Life; Hallucinogens; Isoxazoles; Neurons; Neuroprotective Agents; Neurotoxicity Syndromes; Nicotinic Agonists; Phencyclidine; Phenylurea Compounds; Rats; Rats, Inbred Strains; Receptors, Nicotinic; Tissue Distribution | 2012 |
Increased extracellular glutamate evoked by 1-methyl-4-phenylpyridinium [MPP(+)] in the rat striatum is not essential for dopaminergic neurotoxicity and is not derived from released glutathione.
Topics: 1-Methyl-4-phenylpyridinium; Amino Acids; Animals; Chromatography, High Pressure Liquid; Dopamine; Dopamine Agents; Electrochemistry; Enzyme Inhibitors; Extracellular Space; gamma-Glutamyltransferase; Glutamic Acid; Glutathione; Immunohistochemistry; Isoxazoles; Male; Microdialysis; Neostriatum; Neurotoxicity Syndromes; Rats; Rats, Sprague-Dawley; Serotonin | 2005 |
Cyclooxygenase inhibition attenuates 3-nitropropionic acid-induced neurotoxicity in rats: possible antioxidant mechanisms.
Topics: Animals; Behavior, Animal; Brain; Cyclooxygenase Inhibitors; Glutathione; Isoxazoles; Lipid Peroxidation; Male; Malondialdehyde; Maze Learning; Memory; Motor Activity; Naproxen; Neuroprotective Agents; Neurotoxicity Syndromes; Nitrites; Nitro Compounds; Oxidative Stress; Propionates; Rats; Rats, Wistar; Succinate Dehydrogenase; Sulfonamides | 2007 |
On the role of tyrosine and peripheral metabolism in 3,4-methylenedioxymethamphetamine-induced serotonin neurotoxicity in rats.
Topics: Analysis of Variance; Animals; Antimetabolites; Area Under Curve; Body Temperature; Brain; Catechols; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Hydroxyindoleacetic Acid; Isoxazoles; Male; N-Methyl-3,4-methylenedioxyamphetamine; Neurotoxicity Syndromes; Nitriles; Protein Binding; Rats; Rats, Wistar; Serotonin; Time Factors; Tyrosine | 2008 |
Serotonergic neurotoxicity of 3,4-(+/-)-methylenedioxyamphetamine and 3,4-(+/-)-methylendioxymethamphetamine (ecstasy) is potentiated by inhibition of gamma-glutamyl transpeptidase.
Topics: 3,4-Methylenedioxyamphetamine; Administration, Cutaneous; Animals; Brain; Endothelium; Enzyme Inhibitors; gamma-Glutamyltransferase; Humans; Isoxazoles; Male; Models, Molecular; N-Methyl-3,4-methylenedioxyamphetamine; Neurotoxicity Syndromes; Neurotransmitter Agents; Rats; Rats, Sprague-Dawley; Serotonin; Serotonin Agents | 2001 |